PL EN


Preferences help
enabled [disable] Abstract
Number of results
2019 | 138 | 2 | 225-247
Article title

Factors, impacts and possible solutions of antibiotic resistance: Review article

Authors
Content
Title variants
Languages of publication
EN
Abstracts
EN
The discovery of antibiotics has helped to save the lives of an uncountable number of people. Unfortunately, their misuse and other related factors have led to the emergence and development of bacteria that are resistant to antibiotics. Antimicrobial resistance is one of the most serious threats to public health globally and threatens the ability to treat infectious diseases. The factors that contribute for the emergence and spread of antimicrobial resistance are complex non-prudent use of antibiotics in veterinary and human medicine is, in large part, responsible for the emergence of antibiotic resistance. Inappropriate prescription practices, inadequate education, poor drug quality, limited rapid diagnostic test facilities, poor hygiene, infection prevention and control practice are also other factors contribute for the emergence and spread of antimicrobial resistance. Due to the emergency of new resistant bacteria and decrease in efficiency of treating common infectious diseases, it results in failure of microbial response to standard treatment, leading to prolonged illness, higher expenditures for health care, and an immense risk of death. Considering these serious impacts of antibiotic resistance several solutions have been proposed including antibiotic stewardship, educational program, hygiene, infection prevention and control strategy, adapting rapid methods for detecting resistance bacteria as well as developing new antibiotics and alternative therapeutic agents.
Year
Volume
138
Issue
2
Pages
225-247
Physical description
Contributors
author
  • Department of Biology, Debre Tabor University, P.O. Box 272, Debre Tabor, Ethiopia
References
  • [1] Abera, B., Kibret, M. and Mulu, W. (2014). Knowledge and beliefs on antimicrobial resistance among physicians and nurses in hospitals in Amhara Region, Ethiopia. BioMed Central Pharmacology and Toxicology 15(1): 26.
  • [2] Agrawal, V., Kapoor, S. and Shah, N. (2012). Role of Live Microorganisms' (Probiotics) in Prevention of Caries: Going on the Natural Way Towards Oral Health. Indian Journal of Multidisciplinary Dentistry 2(3): 491-496.
  • [3] Ahmed, K., Kaderbhai, N. N. and Kaderbhai, M. A. (2012). Bacteriophage therapy revisited. African Journal of Microbiology Research 6(14): 3366-3379.
  • [4] Allen, H. K., Trachsel, J., Looft, T. and Casey, T. A. (2014). Finding alternatives to antibiotics. Annals of the New York Academy of Sciences 1323(1): 91-100.
  • [5] Anderson, D. J. and Kaye, K. S. (2009). Controlling antimicrobial resistance in the hospital. Infectious Disease Clinics 23(4): 847-864.
  • [6] Anderson, A. D., Nelson, J. M., Rossiter, S. and Angulo, F. J. (2003). Public health consequences of use of antimicrobial agents in food animals in the United States. Microbial Drug Resistance 9(4): 373-379.
  • [7] Apisarnthanarak, A., Danchaivijitr, S., Khawcharoenporn, T., Limsrivilai, J., Warachan, B., Bailey, T. C., Fraser, V.J. and Thammasart university Antibiotic Management Team. (2006). Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clinical Infectious Diseases 42(6): 768-775.
  • [8] Behrens, R.H., Awad, A.I. and Taylor, R.B. (2002). Substandard and counterfeit drugs in developing countries. Tropical Doctor 32(1): 1–2.
  • [9] Berkley, J. A., Mwangi, I., Ngetsa, C. J., Mwarumba, S., Lowe, B. S., Marsh, K. and Newton, C. R. (2001). Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. The Lancet 357(9270): 1753-1757.
  • [10] Beutler, J. A. (2010). Natural products as a foundation for drug discovery. Current Protocols in Pharmacology 46:9-11.
  • [11] Bonner, A. B., Monroe, K. W., Talley, L. I., Klasner, A. E. and Kimberlin, D. W. (2003). Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial. Pediatrics 112(2): 363-367.
  • [12] Bragg, R., van der Westhuizen, W., Lee, J. Y., Coetsee, E. and Boucher, C. (2014). Bacteriophages as potential treatment option for antibiotic resistant bacteria. In Infectious Diseases and Nanomedicine I (pp. 97-110). Springer, New Delhi.
  • [13] Buke, C., Hosgor-Limoncu, M., Ermertcan, S., Ciceklioglu, M., Tuncel, M., Köse, T. and Eren, S. (2005). Irrational use of antibiotics among university students. Journal of Infection 51(2): 135-139.
  • [14] Bushra, R., Aslam, N. and Khan, A. Y. (2011). Food-drug interactions. Oman Medical Journal 26(2): 77.
  • [15] Cabello, F. C. (2006). Heavy use of prophylactic antibiotics in aquaculture: a growing problem for human and animal health and for the environment. Environmental Microbiology 8(7): 1137-1144.
  • [16] Cantas, L., Shah, S. Q. A., Cavaco, L. M., Manaia, C., Walsh, F., Popowska, M., Garelick, H., Bürgmann, H. and Sørum, H. (2013). A brief multi-disciplinary review on antimicrobial resistance in medicine and its linkage to the global environmental microbiota. Frontiers in Microbiology 14(4): 96.
  • [17] Casewell, M., Friis, C., Marco, E., McMullin, P. and Phillips, I. (2003). The European ban on growth-promoting antibiotics and emerging consequences for human and animal health. Journal of Antimicrobial Chemotherapy 52(2): 159-161.
  • [18] Centres for Disease Control and Prevention (US). (2013). Antibiotic resistance threats in the United States, 2013. Centres for Disease Control and Prevention, US Department of Health and Human Services.
  • [19] Chanishvili, N., Chanishvili, T., Tediashvili, M. and Barrow, P. A. (2001). Phages and their application against drug‐resistant bacteria. Journal of Chemical Technology and Biotechnology 76(7): 689-699.
  • [20] Charlebois, E. D., Bangsberg, D. R., Moss, N. J., Moore, M. R., Moss, A. R., Chambers, H. F., and Perdreau-Remington, F. (2002). Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clinical Infectious Diseases 34(4): 425-433.
  • [21] Chellat, M.F., Raguˇz, L. and Riedl, R. (2016). Targeting antibiotic resistance. Angew Chem Int Ed Engl. 55(23): 6600-26
  • [22] Clinical Infectious Diseases (CID). (2007). Antimicrobial Stewardship Guidelines 44 (2): 159–177.
  • [23] Corbett, K. K., Gonzales, R., Leeman-Castillo, B. A., Flores, E., Maselli, J. and Kafadar, K. (2005). Appropriate antibiotic use: variation in knowledge and awareness by Hispanic ethnicity and language. Preventive Medicine 40(2): 162-169.
  • [24] Cuny, C., Friedrich, A., Kozytska, S., Layer, F., Nübel, U., Ohlsen, K., Strommenger, B., Walther, B., Wieler, L., and Witte, W. (2010). Emergence of methicillin-resistant Staphylococcus aureus (MRSA) in different animal species. International Journal of Medical Microbiology 300(2-3): 109-117.
  • [25] Davey, P. and Garner, S. (2007). Professional education on antimicrobial prescribing: a report from the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Professional Education Subgroup. Journal of Antimicrobial Chemotherapy 60(supl1): 27-32.
  • [26] Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins ,W.C,. Paterson D.L., Fishman, N.O., Carpenter, C.F., Billeter, M., Hooten, T.M. and Brennan, P. J. (2007). Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clinical Infectious Diseases 44(2): 159-177.
  • [27] Dersjant-Li, Y., Awati, A., Kromm, C. and Evans, C. (2013). A direct fed microbial containing a combination of three-strain Bacillus sp. can be used as an alternative to feed antibiotic growth promoters in broiler production. Journal of Applied Animal Nutrition, 2.
  • [28] Dryden, M. S., Cooke, J. and Davey, P. (2009). Antibiotic stewardship—more education and regulation not more availability? Journal of Antimicrobial Chemotherapy 64(5): 885-888.
  • [29] European Commission. (2011). EU research on antimicrobial resistance: EU projects 2007–2010. Brussels: UC; Available from: http://ec.europa.eu/research/health/infectious-diseases/antimicrobial-drug-resistance/pdf/eu-research-on-antimicrobial resistance_en.pdf [accessed 13 September 2012]
  • [30] Fernandes, P. (2006). Antibacterial discovery and development-the failure of success. Nature Biotechnology 24(12): 1497.
  • [31] Finch, R. G., Metlay, J. P., Davey, P. G. and Baker, L. J. (2004). Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. The Lancet Infectious Diseases 4(1): 44-53.
  • [32] Fischer, J., Rodríguez, I., Schmoger, S., Friese, A., Roesler, U., Helmuth, R. and Guerra, B. (2012). Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. Journal of Antimicrobial Chemotherapy 68(2): 478-480.
  • [33] Fishman, N., Society for Healthcare Epidemiology of America, and Infectious Diseases Society of America. (2012). Policy statement on antimicrobial stewardship by the Society for Healthcare Epidemiology of America (SHEA), the Infectious Diseases Society of America (IDSA), and the Pediatric Infectious Diseases Society (PIDS). Infection Control and Hospital Epidemiology 33(4): 322-327.
  • [34] French, G. L. (2010). The continuing crisis in antibiotic resistance. International Journal of Antimicrobial Agents 36: S3-S7.
  • [35] Gordin, F. M., Schultz, M. E., Huber, R. A. and Gill, J. A. (2005). Reduction in nosocomial transmission of drug-resistant bacteria after introduction of an alcohol-based handrub. Infection Control and Hospital Epidemiology 26(7): 650-653.
  • [36] Gueimonde, M., Kalliomäki, M., Isolauri, E. and Salminen, S. (2006). Probiotic intervention in neonates-Will permanent colonization ensue. Journal of Pediatric Gastroenterology and Nutrition 42(5): 604-606.
  • [37] Harbarth, S. and Samore, M. H. (2005). Antimicrobial resistance determinants and future control. Emerging Infectious Diseases 11(6): 794.
  • [38] He, T., Priebe, M. G., Zhong, Y., Huang, C., Harmsen, H. J. M., Raangs, G. C., Antoine, J.M. Welling, G.W. and Vonk, R. J. (2008). Effects of yogurt and bifidobacteria supplementation on the colonic microbiota in lactose‐intolerant subjects. Journal of Applied Microbiology 104(2): 595-604.
  • [39] Huang, S. S., Rifas-Shiman, S. L., Kleinman, K., Kotch, J., Schiff, N., Stille, C. J., Steingard, R. and Finkelstein, J. A. (2007). Parental knowledge about antibiotic use: results of a cluster-randomized, multicommunity intervention. Pediatrics 119(4), 698-706.
  • [40] Ibrahim, F., Ruvio, S., Granlund, L., Salminen, S., Viitanen, M. and Ouwehand, A. C. (2010). Probiotics and immunosenescence: cheese as a carrier. FEMS Immunology and Medical Microbiology 59(1): 53-59.
  • [41] Ignatova, M., Sredkova, V. and Marasheva, V. (2009). Effect of dietary inclusion of probiotic on chicken’s performance and some blood indices. Biotechnology in Animal Husbandry 25(5-6):1079-1085.
  • [42] International Federation of Pharmaceutical Manufacturers and Associations. (2015). Rethinking the way, we fight bacteria. [Online]; [cited 2015 August 3]. Available from: http://bit.ly/1DJhVfE.
  • [43] Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H. and Salminen, S. (2001). Probiotics: effects on immunity–. The American Journal of Clinical Nutrition 73(2): 444s-450s.
  • [44] Issack, M. I. (2001). Substandard drugs. The Lancet 358 (9291): 1463.
  • [45] Kaki, R., Elligsen, M., Walker, S., Simor, A., Palmay, L. and Daneman, N. (2011). Impact of antimicrobial stewardship in critical care: a systematic review. Journal of Antimicrobial Chemotherapy 66(6): 1223-1230.
  • [46] ] Kassenborg, H. D., Smith, K. E., Vugia, D. J., Rabatsky-Ehr, T., Bates, M. R., Carter, M. A. and Angulo, F. J. (2004). Fluoroquinolone-resistant Campylobacter infections: eating poultry outside of the home and foreign travel are risk factors. Clinical Infectious Diseases 38(Supplement_3): S279-S284.
  • [47] Kazakova, S. V., Hageman, J. C., Matava, M., Srinivasan, A., Phelan, L., Garfinkel, B. and Dodson, D. (2005). A clone of methicillin-resistant Staphylococcus aureus among professional football players. New England Journal of Medicine 352(5): 468-475.
  • [48] Langton, K. P., Henderson, P. J., & Herbert, R. B. (2005). Antibiotic resistance: multidrug efflux proteins, a common transport mechanism? Natural Product Reports 22(4): 439-451.
  • [49] Lee, N. Y., Lee, H. C., Ko, N. Y., Chang, C. M., Shih, H. I., Wu, C. J. and Ko, W. C. (2007). Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infection Control and Hospital Epidemiology 28(6): 713-719.
  • [50] ] Levy, S. B. (2005). Antibiotic resistance - the problem intensifies. Advanced Drug Delivery Reviews 57(10): 1446-1450.
  • [51] Livermore, D. M. (2012). Fourteen years in resistance. International Journal of Antimicrobial Agents 39(4): 283-294.
  • [52] Loc-Carrillo, C. and Abedon, S. T. (2011). Pros and cons of phage therapy. Bacteriophage 1(2): 111-114.
  • [53] Luyt, C. E., Bréchot, N., Trouillet, J. L. and Chastre, J. (2014). Antibiotic stewardship in the intensive care unit. Critical Care 18(5): 480.
  • [54] Mainous, A. G., Everett, C. J., Post, R. E., Diaz, V. A. and Hueston, W. J. (2009). Availability of antibiotics for purchase without a prescription on the internet. The Annals of Family Medicine 7(5): 431-435.
  • [55] Malaria Rapid Diagnostic Tests. (2005). [accessed 24 April 2013] Available at: http://www.wpro.who.int/malaria/sites/rdt/
  • [56] Marra, A. R., de Almeida, S. M., Correa, L., Silva, M., Martino, M. D. V., Silva, C. V., Cal, R.G., Edmond, M.B. and dos Santos, O. F. P. (2009). The effect of limiting antimicrobial therapy duration on antimicrobial resistance in the critical care setting. American Journal of Infection Control 37(3): 204-209.
  • [57] Mathews, W. C., Caperna, J. C., Barber, R. E., Torriani, F. J., Miller, L. G., May, S. and McCutchan, J. A. (2005). Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. Journal of Acquired Immune Deficiency Syndromes 40 (2): 155-160.
  • [58] Mathur, M. D., Vidhani, S., Mehndiratta, P. L., Bhalla, P. and Reddy, B. S. N. (2003). Bacteriophage therapy: an alternative to conventional antibiotics. Journal-Association of Physicians of India 51 (8): 593-596.
  • [59] Maurya, R., Singh, G. and Yadav, P. P. (2008). Antiosteoporotic agents from natural sources. In Studies in Natural Products Chemistry 35: 517-548.
  • [60] McAdams D. (2016). Extending the Antibiotic Era: Genomics and the Changing Game of Antibiotic Resistance, Working paper, Duke University.
  • [61] McChesney, J. D., Venkataraman, S. K. and Henri, J. T. (2007). Plant natural products: back to the future or into extinction? Phytochemistry 68(14): 2015-2022.
  • [62] McEllistrem, M. C., Adams, J. M., Patel, K., Mendelsohn, A. B., Kaplan, S. L., Bradley, J. S. and Wald, E. R. (2005). Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clinical Infectious Diseases 40(12): 1738-1744.
  • [63] McEwen, S. A. (2006). Antibiotic use in animal agriculture: what have we learned and where are we going? Animal Biotechnology 17(2): 239-250.
  • [64] McGeer, A., Fleming, C. A., Green, K. and Low, D. E. (2001). Antimicrobial resistance in Ontario: are we making progress. Laboratory Proficiency Testing Program Newsletter 293: 1-4.
  • [65] Melander, E., Jönsson, G. and Mölstad, S. (2000). Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. The Pediatric Infectious Disease Journal 19(12): 1172-1177.
  • [66] Meyer, E., Schwab, F., Schroeren-Boersch, B. and Gastmeier, P. (2010). Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Critical Care 14(3):113.
  • [67] Morgan, D. J., Okeke, I. N., Laxminarayan, R., Perencevich, E. N. and Weisenberg, S. (2011). Non-prescription antimicrobial use worldwide: a systematic review. The Lancet Infectious Diseases 11(9): 692-701.
  • [68] Moteriya, P., Satasiya, R. and Chanda, S. (2015). Screening of phytochemical constituents in some ornamental flowers of Saurashtra region. Journal of Pharmacognosy and Phytochemistry 3(5): 112-120.
  • [69] Nagala, R. and Routray, C. (2011). Clinical case study multispecies probiotic supplement minimizes symptoms of irritable Bowel Syndrome. US Gastroenterology and Hepatology Review 7(1): 36-37.
  • [70] Ndihokubwayo, J. B., Yahaya, A. A., Dester, A. T., Ki-Zerbo, G., Asamoah-Odei, E. and Keita, B. (2013). Antimicrobial resistance in the African Region: Issues, challenges and actions proposed. African Health Monitor 16: 27-30.
  • [71] Nguyen, D. M., Mascola, L. and Brancoft, E. (2005). Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerging Infectious Diseases 11(4): 526-532.
  • [72] Nickerson, E. K., Hongsuwan, M., Limmathurotsakul, D., Wuthiekanun, V., Shah, K. R., Srisomang, P., Mahavanakul, W., Wacharaprechasgul, T., Fowler, V.G., West, T.E., Teerawatanasuk, N., Becher, H., White, N.J., Chierakul, W., Day N.P. and Peacock, S.J. (2009). Staphylococcus aureus bacteraemia in a tropical setting: patient outcome and impact of antibiotic resistance. PLoS One 4(1): e4308.
  • [73] Nordmann, P., Poirel, L., Toleman, M. A. and Walsh, T. R. (2011). Does broad-spectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? Journal of Antimicrobial Chemotherapy 66(4): 689-692.
  • [74] O’Neill, J. (2016). Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance. London: AMR,
  • [75] O’Neill, J. (2016). Vaccines and alternative approaches: Reducing our dependence on antimicrobials. London: AMR,
  • [76] Okeke, I. N., Laxminarayan, R., Bhutta, Z. A., Duse, A. G., Jenkins, P., O'Brien, T. F., Pablos-Mendez, A. and Klugman, K. P. (2005). Antimicrobial resistance in developing countries. Part I: recent trends and current status. The Lancet Infectious Diseases 5(8): 481-493.
  • [77] Palmer, A. C. and Kishony, R. (2013). Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance. Nature Reviews Genetics 14(4): 243.
  • [78] Pápai, K., Budai, M., Ludányi, K., Antal, I. and Klebovich, I. (2010). In vitro food–drug interaction study: Which milk component has a decreasing effect on the bioavailability of ciprofloxacin? Journal of Pharmaceutical and Biomedical Analysis 52(1):37-42.
  • [79] Prazuck, T., Falconi, I., Morineau, G., Bricard-Pacaud, V., Lecomte, A. and Ballereau, F. (2002). Quality control of antibiotics before the implementation of an STD program in Northern Myanmar. Sexually Transmitted Diseases 29(11): 624-627.
  • [80] Pumart, P., Phodha, T., Thamlikitkul, V., Riewpaiboon, A., Prakongsai, P. and Limwattananon, S. (2012). Health and economic impacts of antimicrobial resistance in Thailand. Journal of Health Systems Research 6(3): 352-60.
  • [81] Purdom, G. (2014). Antibiotic Resistance of Bacteria: An Example of Evolution in Action? | Health Impact News. Retrieved September 21, from http://healthimpactnews.com/2011/
  • [82] Ram, J., Moteriya, P. and Chanda, S. (2015). Phytochemical screening and reported biological activities of some medicinal plants of Gujarat region. Journal of Pharmacognosy and Phytochemistry 4(2): 192-198.
  • [83] Reardon, S. (2015). Bacterial arms race revs up. Nature 521(7553), 402-403.
  • [84] Reid, G., Howard, J. and Gan, B. S. (2001). Can bacterial interference prevent infection? Trends in microbiology 9(9): 424-428.
  • [85] Review on Antimicrobial Resistance. (2015). Securing new drugs for future generations: the pipeline of antibiotics. Review on Antimicrobial Resistance.
  • [86] Rhodes, G., Huys, G., Swings, J., Mcgann, P., Hiney, M., Smith, P. and Pickup, R. W. (2000). Distribution of oxytetracycline resistance plasmids between aeromonads in hospital and aquaculture environments: implication of Tn1721 in dissemination of the tetracycline resistance determinant Tet A. Applied and Environmental Microbiology 66(9): 3883-3890.
  • [87] Ritchie, M. L. and Romanuk, T. N. (2012). A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 7(4): e34938.
  • [88] Roberts, R. R., Hota, B., Ahmad, I., Scott, R. D., Foster, S. D., Abbasi, F., Schabowski, S., Kampe, L.M., Ciavarella, G.G., Supino, M., Naples, J., Cordell, R., Levy, S.B., Weinstein, R.A. (2009). Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases 49(8): 1175-1184.
  • [89] Rossolini, G. M., Mantengoli, E., Docquier, J., Musmanno, R. A. and Coratza, G. (2007). Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains. New Microbiology 30(3): 332.
  • [90] Rout, S. P., Choudary, K. A., Kar, D. M., Das, L. O. P. A. M. U. D. R. A. and Jain, A. (2009). Plants in traditional medicinal system-future source of new drugs. International Journal of Pharmacognosy and Phytochemistry Science 1(1): 1-23.
  • [91] Saraf, K., Shashikanth, M. C., Priy, T., Sultana, N. Journal of Pharmacognosy and Phytochemistry Chaitanya, N. C. (2010). Probiotics-Do they have a Role in Medicine and Dentistry. Journal-Association of Physicians of India 58: 488-492.
  • [92] Schnellinger, M., Finkelstein, M., Thygeson, M. V., Vander Velden, H., Karpas, A. and Madhok, M. (2010). Animated video vs pamphlet: comparing the success of educating parents about proper antibiotic use. Pediatrics 125(5): 990-996.
  • [93] Shah, S. Q., Colquhoun, D. J., Nikuli, H. L. and Sørum, H. (2012). Prevalence of antibiotic resistance genes in the bacterial flora of integrated fish farming environments of Pakistan and Tanzania. Environmental Science and Technology 46(16): 8672-8679.
  • [94] Shakoor, O., Taylor, R. B. and Behrens, R. H. (1997). Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine and International Health 2(9): 839-845.
  • [95] Sharma, V., Dowd, M. D., Slaughter, A. J. and Simon, S. D. (2002). Effect of rapid diagnosis of influenza virus type A on the emergency department management of febrile infants and toddlers. Archives of Pediatrics and Adolescent Medicine 156(1): 41-43.
  • [96] Bowen M., 2013. Antimicrobial stewardship: Time for change. Equine Veterinary Journal, 45: 127-129. DOI: 10.1111/evj.12041
  • [97] Siegel, J. D., Rhinehart, E., Jackson, M. and Chiarello, L. (2007). Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infection Control 35(10): S165-S193.
  • [98] Silbergeld, E. K., Graham, J. and Price, L. B. (2008). Industrial food animal production, antimicrobial resistance, and human health. Annual Review of Public Health 29: 151-169.
  • [99] Spellberg, B. (2010, December). The antibacterial pipeline: why is it drying up and what must be done about it? In Antibiotic resistance: implications for global health and novel intervention strategies: workshop summary (pp. 299-332). Institute of Medicine, Washington.
  • [100] Spellberg, B. (2011). The Antibiotic Crisis: Can We Reverse 65 Years of Failed Stewardship? Comment on “Decreased Antibiotic Utilization After Implementation of a Guideline for Inpatient Cellulitis and Cutaneous Abscess”. Archives of Internal Medicine 171(12): 1080-1081.
  • [101] Spellberg, B., Bartlett, J. G. and Gilbert, D. N. (2013). The future of antibiotics and resistance. New England Journal of Medicine 368(4): 299-302.
  • [102] Spellberg, B., Guidos, R., Gilbert, D., Bradley, J., Boucher, H. W., Scheld, W. M. and Infectious Diseases Society of America. (2008). The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clinical Infectious Diseases 46(2): 155-164.
  • [103] Spellberg, B., Powers, J. H., Brass, E. P., Miller, L. G. and Edwards, J. E. (2004). Trends in antimicrobial drug development: implications for the future. Clinical Infectious Diseases 38(9): 1279-1286.
  • [104] Sumpradit, N., Chongtrakul, P., Anuwong, K., Pumtong, S., Kongsomboon, K., Butdeemee, P. Khonglormyati, J., Chomyong, S., Tongyoung, P., Losiriwat, S., Suwanwaree, P., Tangcharoensathien V. and Seesuk, P. (2012). Antibiotics Smart Use: a workable model for promoting the rational use of medicines in Thailand. Bulletin of the World Health Organization 90: 905-913.
  • [105] Syhakhang, L., Lundborg, C. S., Lindgren, B. and Tomson, G. (2004). The quality of drugs in private pharmacies in Lao PDR: a repeat study in 1997 and 1999. Pharmacy World and Science 26(6): 333-338.
  • [106] Sykes, R. (2001). Penicillin: from discovery to product. Bulletin of the World Health Organization 79(8): 778-779.
  • [107] Taylor, J., Hafner, M., Yerushalmi, E., Smith, R., Bellasio, J., Vardavas, R., Bienkowska-Gibbs, T. and Rubin, J. (2014). Estimating the economic costs of antimicrobial resistance. Model and Results (RAND Corporation, Cambridge, UK).
  • [108] Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A. and Laxminarayan, R. (2015). Global trends in antimicrobial use in food animals. Proceedings of the National Academy of Sciences 112(18): 5649-5654.
  • [109] Vargas, J., Carballo, M., Hernández, M., Rojas, N., Jiménez, O., Riera, J., Romero, L., Rodriguez-Morales, A.J. and Silva, M. (2005). Rapid development of auricular infection due to imipenem-resistant Pseudomonas aeruginosa following self-administered piercing of high ear. Clinical Infectious Diseases-Chicago 41(12), 1823.
  • [110] Veizaj-Delia, E., Piu, T., Lekaj, P. and Tafaj, M. (2010). Using combined probiotic to improve growth performance of weaned piglets on extensive farm conditions. Livestock Science 134(1):249-251.
  • [111] Weinstein RA. (2000) Controlling antimicrobial drug resistance: the role of infection control and antimicrobial use. Program of the 4th Decennial International Conference on Nosocomial and Healthcare- Associated Infections. Atlanta, Georgia, March 5-9, 2000:7
  • [112] Whitelaw, A. C. (2015). Role of infection control in combating antibiotic resistance. South African Medical Journal 105(5): 423-423.
  • [113] World Health Organization. (2009). WHO guidelines on hand hygiene in healthcare. http:// whqlibdoc.who.int/publications/2009/9789241597906_eng.pdf (accessed 8 April 2015).
  • [114] World Health Organization. (2012). The evolving threat of antimicrobial resistance: options for action. World Health Organization.
  • [115] World Health Organization. (2014). The evolving threat of antimicrobial resistance: options for action. 2012. Geneva, Switzerland: World Health Organization Google Scholar.
  • [116] World Health Organization. (2015). WHO multi-country survey reveals widespread public misunderstanding about antibiotic resistance. World Health Organisation [Internet], 1-7.
  • [117] World Health Organization. (2017). Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis.
  • [118] World Health Organization (2012).World Health Report: Shaping the future. http://www.who.int/whr/2003/en/ (30th April).
  • [119] Yoneyama, H. and Katsumata, R. (2006). Antibiotic resistance in bacteria and its future for novel antibiotic development. Bioscience, Biotechnology, and Biochemistry 70(5): 1060-1075.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-c2875926-56bc-4d94-8ab4-574e0a5de1ac
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.